Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study
Michelle C. Williams(University of Edinburgh), Edward Nicol(Royal Brompton & Harefield NHS Foundation Trust), Amanda Hunter(Golden Jubilee National Hospital), Tania Pawade(MACOM (United States)), Shirjel Alam(MACOM (United States)), Jonathan Weir‐McCall(King's College - North Carolina), Alastair J. Moss(MACOM (United States)), Marc R. Dweck(University of Edinburgh), Anoop Shah(Imperial College Healthcare NHS Trust), Edwin J.R. van Beek(University of Edinburgh), Philip D Adamson(Christchurch Hospital), David E. Newby(University of Edinburgh), Giles Roditi(Glasgow Royal Infirmary)
Cited by 593
Related Papers
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
|European Heart Journal|2022|1.3k
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
|The Lancet|2013|942
Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure
|Particle and Fibre Toxicology|2005|929
Estimates of the global burden of cervical cancer associated with HIV
|The Lancet Global Health|2020|912
Adverse cardiovascular effects of air pollution
|Nature Clinical Practice Cardiovascular Medicine|2008|778